Hospital Dermatológico de Jorochito Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01300975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hospital Dermatologico de Jorochito | Hospital Dermatológico de Jorochito

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 3)

Leishmaniasis, Cutaneous (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4